Christopher J. DeRespino
Plus aucun poste en cours
Profil
Christopher J.
DeRespino worked as an Executive Director of Business Development at Amgen, Inc. from 2018 to 2021.
Prior to that, he worked as a Director of Business Development at Onyx Pharmaceuticals, Inc. He also briefly served as the Chief Financial, Accounting & Business Officer at Adverum Biotechnologies, Inc. in 2021.
DeRespino received his undergraduate degree from The Johns Hopkins University and his MBA from The Leonard N Stern School of Business.
Anciens postes connus de Christopher J. DeRespino
Sociétés | Poste | Fin |
---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Director of Finance/CFO | 27/08/2021 |
AMGEN INC. | Corporate Officer/Principal | 01/02/2021 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Formation de Christopher J. DeRespino
The Johns Hopkins University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
AMGEN INC. | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |